Treatment failure in giant cell arteritis

OBJECTIVE: Identify predictors of treatment failure in patients with giant cell arteritis (GCA) receiving tocilizumab in combination with glucocorticoids and in patients with GCA receiving only glucocorticoids. METHODS: Posthoc analysis of the Giant-Cell Arteritis Actemra trial including 250 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Unizony, Sebastian H, Bao, Min, Han, Jian, Luder, Yves, Pavlov, Andrey, Stone, John H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522464/
https://www.ncbi.nlm.nih.gov/pubmed/34049857
http://dx.doi.org/10.1136/annrheumdis-2021-220347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522464/
https://www.ncbi.nlm.nih.gov/pubmed/34049857
http://dx.doi.org/10.1136/annrheumdis-2021-220347

Ejemplares similares